← All stocks

InspireMD, Inc.

NSPR Net buying
CIK 0001433607 #4780 in the set updated 17 Sep 2026
Bought (12 mo)
$425.04K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$127.01K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$127.01K
12 of 12 sales
Net
+$298.03K
+$298.03K against sales at will

By person

14 insiders · 27 transactions
5.2×

Marvin Slosman holds 5.2 times base salary in stock. $3.11M of shares against $588.50K in salary for 2025.

Salary from the company's own proxy. The shares are what Marvin Slosman last reported holding, valued at $0.88, the price Common Stock was last bought or sold at on the open market here, on 27 May 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Stuka Paul
Director
$191.00K (11)
+$191.00K
1,112,066
2.39%
$973.06K
+65.8%
Gleason Shane Thomas
Chief Commercial Officer
$127.01K (12)
−$127.01K
1,053,882
2.27%
$922.15K
+104.9%
ROUBIN GARY S
Director
$106.20K (1)
+$106.20K
834,478
1.79%
$730.17K
+65.6%
Ward Scott R.
Director
$102.64K (2)
+$102.64K
237,096
0.5100%
$207.46K
+444.4%
Slosman Marvin
CEO and President
$25.20K (1)
+$25.20K
3,556,658
7.65%
$3.11M
+92.0%
Shore Craig
CFO and CAO
1,112,460
2.39%
$973.40K
+26.4%
Tommasoli Andrea
Chief Operating Officer
954,389
2.05%
$835.09K
+92.8%
Lawless Michael A
Chief Financial Officer
691,695
1.49%
$605.23K
+48.8%
BERMAN MICHAEL
Director
597,580
1.29%
$522.88K
+43.7%
Kester Thomas J
Director
458,573
0.9864%
$401.25K
+40.4%
Verta Patrick
EVP Clinical/Medical Affairs
311,532
0.6701%
$272.59K
+36.4%
Arnold Kathryn
Director
303,087
0.6520%
$265.20K
+40.9%
Dearen Danny L.
Director
102,047
0.2195%
$89.29K
+75.9%
COHEN RAYMOND W
Director
92,417
0.1988%
$80.86K
+91.0%
Insider
Date
Role
Action
Shares
Price
Amount
Stuka Paul
27 May 2026
Director
Buy
20,000
$0.88
$17.50K
Gleason Shane Thomas
19 May 2026
Chief Commercial Officer
Sell
22,778
$1.01
$23.01K
Stuka Paul
14 May 2026
Director
Buy
5,000
$1.15
$5.75K
Stuka Paul
13 May 2026
Director
Buy
10,000
$1.16
$11.58K
Slosman Marvin
12 May 2026
CEO and President
Buy
21,000
$1.20
$25.20K
Stuka Paul
11 May 2026
Director
Buy
10,000
$1.19
$11.90K
Stuka Paul
8 May 2026
Director
Buy
65,626
$1.16
$76.13K
ROUBIN GARY S
7 May 2026
Director
Buy
90,000
$1.18
$106.20K
Stuka Paul
7 May 2026
Director
Buy
6,378
$1.15
$7.33K
Ward Scott R.
7 May 2026
Director
Buy
73,255
$1.15
$84.24K
Stuka Paul
6 May 2026
Director
Buy
1,517
$1.12
$1.70K
Ward Scott R.
6 May 2026
Director
Buy
15,995
$1.15
$18.39K
Gleason Shane Thomas
2 Feb 2026
Chief Commercial Officer
Sell
2,000
$1.60
$3.21K
Gleason Shane Thomas
2 Feb 2026
Chief Commercial Officer
Sell
2,941
$1.59
$4.68K
Gleason Shane Thomas
30 Jan 2026
Chief Commercial Officer
Sell
2,900
$1.63
$4.73K
Gleason Shane Thomas
29 Jan 2026
Chief Commercial Officer
Sell
5,000
$1.65
$8.25K
Gleason Shane Thomas
28 Jan 2026
Chief Commercial Officer
Sell
12,395
$1.65
$20.46K
Gleason Shane Thomas
27 Jan 2026
Chief Commercial Officer
Sell
4,781
$1.66
$7.96K
Gleason Shane Thomas
22 Jan 2026
Chief Commercial Officer
Sell
8,411
$1.57
$13.24K
Gleason Shane Thomas
21 Jan 2026
Chief Commercial Officer
Sell
17,593
$1.62
$28.55K
Gleason Shane Thomas
20 Jan 2026
Chief Commercial Officer
Sell
2,955
$1.59
$4.71K
Gleason Shane Thomas
16 Jan 2026
Chief Commercial Officer
Sell
2,250
$1.61
$3.63K
Gleason Shane Thomas
15 Jan 2026
Chief Commercial Officer
Sell
2,909
$1.58
$4.59K
Stuka Paul
9 Dec 2025
Director
Buy
5,073
$1.81
$9.18K
Stuka Paul
5 Dec 2025
Director
Buy
5,073
$1.86
$9.44K
Stuka Paul
4 Dec 2025
Director
Buy
10,130
$1.85
$18.74K
Stuka Paul
12 Nov 2025
Director
Buy
13,431
$1.62
$21.76K

What was left out

Form 4 filings counted 26
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 12
Transactions with no price 0
Shares from compensation/vesting 2,609,423
History held since 8 Sep 2016